Application 200082

Type
ANDA
Sponsor
MYLAN PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EZETIMIBE; SIMVASTATINEZETIMIBE; SIMVASTATINTABLET; ORAL10MG; 10MGNoNo
002EZETIMIBE; SIMVASTATINEZETIMIBE; SIMVASTATINTABLET; ORAL10MG; 20MGNoNo
003EZETIMIBE; SIMVASTATINEZETIMIBE; SIMVASTATINTABLET; ORAL10MG; 40MGNoNo
004EZETIMIBE; SIMVASTATINEZETIMIBE; SIMVASTATINTABLET; ORAL10MG; 80MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A200082-001EZETIMIBE AND SIMVASTATINEZETIMIBE; SIMVASTATIN10MG;10MGTABLET / ORALAB2020-12-17
A200082-002EZETIMIBE AND SIMVASTATINEZETIMIBE; SIMVASTATIN10MG;20MGTABLET / ORALAB2020-12-17
A200082-003EZETIMIBE AND SIMVASTATINEZETIMIBE; SIMVASTATIN10MG;40MGTABLET / ORALAB2020-12-17
A200082-004EZETIMIBE AND SIMVASTATINEZETIMIBE; SIMVASTATIN10MG;80MGTABLET / ORALAB2020-12-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A200082-001AB
A200082-002AB
A200082-003AB
A200082-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A200082-001EZETIMIBE AND SIMVASTATIN10MG;10MGTABLET / ORALAB2020-12-17a50c72e98297…
2026-08-01 22:54:322026-06A200082-002EZETIMIBE AND SIMVASTATIN10MG;20MGTABLET / ORALAB2020-12-17a50c72e98297…
2026-08-01 22:54:322026-06A200082-003EZETIMIBE AND SIMVASTATIN10MG;40MGTABLET / ORALAB2020-12-17a50c72e98297…
2026-08-01 22:54:322026-06A200082-004EZETIMIBE AND SIMVASTATIN10MG;80MGTABLET / ORALAB2020-12-17a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A200082-001AB1a50c72e98297…
2026-08-01 22:54:322026-06A200082-002AB1a50c72e98297…
2026-08-01 22:54:322026-06A200082-003AB1a50c72e98297…
2026-08-01 22:54:322026-06A200082-004AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ezetimibe and SimvastatinEZETIMIBE AND SIMVASTATINAurobindo Pharma Limited79dadfde-35c7-4937-9c82-1728fb6be2fb2024-10-22Warnings, Adverse reactionsExact identifier
application applno (ANDA): 200082
application number: ANDA200082